Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

paul_chew_medlo

Sanofi appoints Paul Chew as chief medical officer

October 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Paul Chew, Sanofi

Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …

Appointment
sanofi_hq_reception_close

Sanofi to cut 900 jobs in France

September 26, 2012
Research and Development Jobs, Sanofi, pharma job cuts, restructuring

Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …

News

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

News

Sanofi cleared in sales row

September 20, 2012
Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi

Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …

News
Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012
Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …

News
Genzyme

Genzyme MS drug approved in US

September 13, 2012
Medical Communications Aubagio, Genzyme, Rebif, Sanofi, Tysabri, gilenya, multiple sclerosis

US regulators have given the green light for Genzyme’s Aubagio to treat patients with relapsing forms of multiple sclerosis (MS). …

News

Sanofi’s colorectal cancer drug gains FDA approval

August 6, 2012
Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer

The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …

News

Negative overtures persuade Sanofi to withdraw drug filing

July 10, 2012
Sales and Marketing EMA, Mulsevo, Sanofi, blood clots, withdrawal

Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …

News

More job cuts planned at Sanofi, says union

July 6, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts

Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …

News
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012
Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

News

Sanofi submits key MS pill for approval

June 12, 2012
Research and Development, Sales and Marketing Bayer, EMA, FDA, Genzyme, Lemtrada, MS, Sanofi

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …

News

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012
Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …

News
Richard Bergstrom

Public-private alliance to discover new antibiotics

May 25, 2012
AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection

 A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …

News

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

News
Genzyme image

Genzyme boosts capacity following green light for Waterford plant

May 8, 2012
Manufacturing and Production EMA, FDA, Genzyme, Sanofi, Waterford

Sanofi subsidiary Genzyme has doubled its capacity to fill-and-finish two of its drugs for rare disorders following approval of a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025